17 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
industry, the global economy, including inflation and financial and credit market fluctuations, or the global supply chain;
our ability to obtain
424B5
ABOS
Acumen Pharmaceuticals Inc
17 Jul 23
Prospectus supplement for primary offering
4:49pm
, the global economy, including inflation and financial and credit market fluctuations, or the global supply chain;
our ability to obtain and maintain
S-3
j6uebl3zch1lt nbfk
1 Jul 22
Shelf registration
5:06pm
10-K
8sakn 5hlpeyv
28 Mar 22
Annual report
4:51pm
10-Q
xbidn3o0c6qk
16 Aug 21
Quarterly report
4:51pm
424B4
u1q p7vmnezlwuwu
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.2
64y43hmf5m1bwl52cj
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
dk0fagn ru793977
24 Jun 21
IPO registration (amended)
8:17am
S-1
uddn0b4sn4savpa85g
9 Jun 21
IPO registration
5:02pm
DRS/A
qob0g
14 May 21
Draft registration statement (amended)
12:00am
DRS
ajv6scldeojdy7 4w89l
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next